Algorithm for the introduction of rapid‐acting insulin analogues in patients with type 2 diabetes on basal insulin therapy
Authors:
- OwensOWOwens
- C van SchalkwykCSC van Schalkwyk
- P SmithPSP Smith
- S BeerSBS Beer
- N GoenkaNGN Goenka
- Sc BainSBSc Bain
- S BootleSBS Bootle
- D RobertsonDRD Robertson
- A RobinsonARA Robinson
- Jam ShawJSJam Shaw
- 1 March 2009
- journal article
- review article
- Published by Wiley in Practical Diabetes International
- Vol. 26 (2) , 70-77
Abstract
More than 4% of men and 3% of women in the UK are known to have type 2 diabetes. Furthermore, an ageing population and increasing prevalence of obesity, both associated with the onset of diabetes, mean that the number of people with the condition is expected to rise dramatically. Uncontrolled diabetes can lead to the development of complications such as retinopathy, neuropathy and myocardial infarction, the treatment of which places an ever increasing burden on health care services. The incidence of such complications can be reduced by adequate glycaemic control, and this can be achieved using an evolving therapeutic strategy which comprises a variety of treatment options involving oral hypoglycaemic agents and insulin preparations, tailored to meet the progressive nature of the condition. Diet and lifestyle modifications have limited long‐term success in maintaining glycaemic control, and it is recommended that metformin, an oral hypoglycaemic agent, is introduced from diagnosis. Meal‐related blood glucose peaks pose a particular challenge to achieving overall glycaemic control, and the introduction of prandial insulin using short‐acting insulin analogues is effective in quickly lowering postprandial blood glucose.This article presents an algorithm that has been developed to provide guidance to health care professionals on the use of prandial insulin to control excessive post‐meal glycaemic excursions in persons with type 2 diabetes inadequately controlled (HbA1c >7%) on basal insulin, with or without oral hypoglycaemic agents. Copyright ©2009 John Wiley & Sons.Keywords
This publication has 39 references indexed in Scilit:
- The Unite for Diabetes campaign: Overcoming constraints to find a global policy solutionGlobalization and Health, 2008
- Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapyDiabetologia, 2007
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2006
- The reality of glycaemic control in insulin treated diabetes: defining the clinical challengesInternational Journal of Obesity, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic PatientsDiabetes Care, 2003
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- Diabetes and Cardiovascular DiseaseJAMA, 1979